![Juergen Froehlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/05/2026
Dr. Juergen K.
Froehlich is a Chief Medical Officer at Arcturus Therapeutics Holdings, Inc. and an Independent Director at Appili Therapeutics, Inc. He is on the Board of Directors at Appili Therapeutics, Inc. Dr. Froehlich was previously employed as a Chief Marketing Officer by EnBiotix, Inc., a Chief Medical & Development Officer by Spexis Ltd., a Chief Medical Officer & Head-Regulatory Affairs by Aradigm Corp., and a Head-Regulatory Affairs by Vertex Pharmaceuticals, Inc. He received his MBA from State University of New York at Albany, an MBA from Graduate School of Business Administration Zürich and a doctorate degree from Julius-Maximilians-Universität Würzburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| APPILI THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/01/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Directeur Technique/Scientifique/R&D | - |
| Sociétés | Poste | Fin |
|---|---|---|
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Sales & Marketing | 01/04/2023 |
| SPEXIS AG | Directeur Technique/Scientifique/R&D | 01/03/2023 |
| ARADIGM CORPORATION | Directeur Technique/Scientifique/R&D | 11/02/2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Conseiller Juridique Général | 01/09/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Graduate School of Business Administration Zürich
 Graduate School of Business Administration Zürich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Appili Therapeutics, Inc.
 Appili Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for infectious disease | Health Technology |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
